- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05340920
Relevance of Sensitization to Fenugreek in Children
April 15, 2022 updated by: Amandine DIVARET-CHAUVEAU, Central Hospital, Nancy, France
The prevalence of allergy to legumes is inscreasing, especially in children and for some of these legumes, little is known and there are not included in the list of priority allergen.
The overall goal of this study is to improve knowledge about fenugreek allergy.
The principal aim is to evaluate the prevalence of allergy to fenugreek confirmed by a positive oral food challenge in children sensitized to fenugreek.
The secondary objectives are to describe the case of allergy to fenugreek (co-allergies, severity, age..), to evaluate diagnostic values of skin prick-tests and specific IgE and to compare the molecular profile of specific IgE to peanut between sensitization to fenugreek without allergy and sensitization with a confirmed allergy
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Amandine Divaret-Chauveau, MD
- Phone Number: +33 630094606
- Email: a.chauveau@chru-nancy.fr
Study Contact Backup
- Name: Timé Muller, MD
- Phone Number: +33 630336839
- Email: t.muller@chru-nancy.fr
Study Locations
-
-
-
Vandœuvre-lès-Nancy, France, 54511
- Centre Hospitalo-Universitaire de Nancy
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 17 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
children aged from 1 to 17 years old, sensitized to fenugreek with an evaluation of their tolerance to fenugreek by an oral food challenge
Description
Inclusion Criteria:
- Children for whom an oral food challenge to fenugreek has been performed between the 1st January 2017 and the 15th April 2022 and for whom skin prick test and/or specific IgE to fenugreek are avalaible
Exclusion Criteria:
- patient over 18 years old
- undeterminate oral food challenge
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oral food challenge to fenugreek
Time Frame: 2017-2022
|
Astier's score 0 to 4 (0=negative, 1 and 2=mild to moderate reaction, 3 and 4 = severe reaction)
|
2017-2022
|
skin prick-test to fenugreek
Time Frame: 2017-2022
|
skin prick test positive if wheal size superior to 3mm
|
2017-2022
|
specific IgE to fenugreek
Time Frame: 2017-2022
|
specific IgE positive if value superior to 0.35kU/L
|
2017-2022
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
severity of allergy
Time Frame: 2017-2022
|
reactogenic dose (from 1 to 1000mg of fenugreek)
|
2017-2022
|
molecular profile for peanut allergy
Time Frame: 2017-2022
|
IgE values for rAra h1, h2, h3, h6, h8, h9
|
2017-2022
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Amandine Divaret-Chauveau, MD, Centre Hospitalo-Universitaire de Nancy
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
April 1, 2022
Primary Completion (Anticipated)
May 1, 2022
Study Completion (Anticipated)
June 1, 2022
Study Registration Dates
First Submitted
April 8, 2022
First Submitted That Met QC Criteria
April 15, 2022
First Posted (Actual)
April 22, 2022
Study Record Updates
Last Update Posted (Actual)
April 22, 2022
Last Update Submitted That Met QC Criteria
April 15, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021PI211
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Allergy to Fenugreek
-
Paola MiciulloCompleted
-
Hong Kong Sanatorium & HospitalChinese University of Hong KongTerminatedAllergy to Fish | Allergy to Shrimp | Allergy to CrabHong Kong
-
Abionic SAJohns Hopkins University; NAMSAWithdrawnAllergy | Allergic Asthma | Allergy to Cats | Allergy to House Dust | Allergy Cockroach | Allergy to Dog Dander (Finding) | Allergy MoldUnited States
-
Abionic SAJohns Hopkins University; NAMSAWithdrawnAllergy | Allergic Asthma | Allergy to Cats | Allergy to House Dust | Allergy to Dog Dander | Allergy CockroachUnited States
-
Sayantani B. SindherNational Institute of Allergy and Infectious Diseases (NIAID)TerminatedAllergy;Food | Allergy to Shrimp | Allergy to Cashew Nut (Disorder)United States
-
University Hospital, RouenCompletedAllergy to Egg | Allergy to PeanutFrance
-
University of ZurichImVision AGCompletedAllergy to CatsSwitzerland
-
Mahidol UniversityActive, not recruitingImmunotherapy | Allergy to ShrimpThailand
-
Laboratorios Leti, S.L.Completed
-
George StavroulakisOdense University Hospital; Medical University of Lodz; National and Kapodistrian... and other collaboratorsCompletedFood Allergy to FishDenmark, Greece, Iceland, Netherlands, Poland, Spain
Clinical Trials on Oral Food Challenge
-
Hôpital Armand TrousseauCompletedReflux, Gastroesophageal | Atopic Dermatitis | Tolerance | Proctocolitis | Food Allergy in InfantsFrance
-
National Jewish HealthCompletedEgg Allergy | Peanut Allergy | Milk AllergyUnited States
-
Hamilton Health Sciences CorporationCanadian Institutes of Health Research (CIHR); AAAAI FoundationRecruiting
-
University Hospital, GenevaTerminatedPeanut Allergy | Food Allergy | Tree Nut AllergySwitzerland
-
IRCCS Burlo GarofoloCompleted
-
Martini Hospital GroningenRecruitingCow Milk Allergy | Food AllergyNetherlands
-
University of Colorado, DenverTerminated
-
University of MichiganRecruitingHealthy | Atopic Dermatitis | Food AllergyUnited States
-
Mahidol UniversityCompletedFood (Shrimp) AllergyThailand